| C. | 1) Candida C. Albicans C. Guillier... |
|---|---|
| BOT | botulinum toxin |
| BTX | botulinum toxin; brevetoxin |
| BT | Botulinum A toxin |
|---|---|
| Botox | Botulinum A toxin |
| BoNT/A | Botulinum Neurotoxin A |
| BoTx | Botulinum Toxin |
| BtxA | Botulinum Toxin A |
| botulinum antitoxin | An equine antitoxin against the toxins produced by the type a, b, or e strain of clostridium botulinum. Generally trivalent (abe) antitoxin is used. (12 Dec 1998) |
|---|---|
| botulinum toxin | <protein> Neurotoxin (50 kD, 7 distinct serotypes) produced by certain strains of Clostridium botulinum. The bacterium produces the toxin as a complex with a haemagglutinin that prevents toxin inactivation in the gut. Proteolysis in the body results in cleavage into two fragments A and B. B binds to gangliosides and may stimulate the endocytosis of fragment A. See: synaptobrevin, tetanus toxin. (18 Nov 1997) |
| botulinum toxins | <chemical> Toxins produced by clostridium botulinum. There are at least seven different substances, most being proteins. They have neuro-, entero-, and haemotoxic properties, are immunogenic, and include the most potent poisons known. The most commonly used apparently blocks release of acetylcholine at cholinergic synapses. Pharmacological action: anti-dyskinesia agents. (12 Dec 1998) |
| botulinum toxin type a | <chemical> A neurotoxin produced by clostridium botulinum. When consumed in contaminated food it can cause paralysis and death. In its purified form, it has been used in the treatment of blepharospasm and strabismus. Pharmacological action: neuromuscular agents. (12 Dec 1998) |
| clostridium botulinum | The aetiologic agent of botulism in man, wild ducks, and other waterfowl. It is also responsible for certain forms of forage poisoning in horses and cattle. The bacterium produces a powerful exotoxin that is resistant to proteolytic digestion. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|